Item 1.01 Entry into a Material Definitive Agreement.
On
The sales, if any, of shares of Series B Preferred Stock made under the Sales
Agreement through
The Company has no obligation to sell any shares of Series B Preferred Stock
under the Sales Agreement, and may at any time suspend offers under the Sales
Agreement. The Sales Agreement will terminate upon the issuance and sale of all
Series B Preferred Stock subject to the Sales Agreement.
The Sales Agreement contains customary representations, warranties and agreements by the Company, as well as indemnification obligations of the Company for certain liabilities under the Act.
The sales and issuances of the shares of Series B Preferred Stock under the
Sales Agreement will be made pursuant to the Company's effective shelf
registration statement on Form S-3 (File No. 333-255094) and the accompanying
prospectus. On the date hereof, the Company intends to file a prospectus
supplement with the
This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
The foregoing description of the Sales Agreement does not purport to be complete and is qualified entirely by reference to the text of such document, a copy of which is attached as an exhibit to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description 1.1 At Market Issuance Sales Agreement datedFebruary 14, 2022 by and betweenCareCloud, Inc. andB. Riley Securities, Inc. 5.1 Opinion ofSong P.C. 23.1 Consent ofSong P.C. (included in Exhibit 5.1 above) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
© Edgar Online, source